Skip to main content
. 2020 Oct 28;11:456. doi: 10.1186/s13287-020-01966-3

Fig. 2.

Fig. 2

Schematic presentation of epidrugs’ effect on the promotion of osteogenesis. After treatment of MSCs with epidrugs, there is a decrease in the epigenetic marks responsible for the silencing genes (DNA methylation, histone methylation) and an increase in gene-activating epigenetic marks (histone acetylation) in osteogenic genes, which result in promotion of osteogenesis